DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 204 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,582,000 | -53.8% | 128,068 | -14.4% | 0.00% | -50.0% |
| Q2 2021 | $5,587,000 | +207.8% | 149,686 | +110.8% | 0.00% | +100.0% |
| Q1 2021 | $1,815,000 | +184.0% | 70,992 | +144.6% | 0.00% | – |
| Q4 2020 | $639,000 | -90.1% | 29,018 | -91.9% | 0.00% | -100.0% |
| Q3 2020 | $6,478,000 | +216.3% | 360,090 | +346.7% | 0.00% | +300.0% |
| Q2 2020 | $2,048,000 | +21.7% | 80,612 | -12.1% | 0.00% | -50.0% |
| Q1 2020 | $1,683,000 | +216.4% | 91,662 | +279.9% | 0.00% | +100.0% |
| Q4 2019 | $532,000 | +247.7% | 24,127 | +131.7% | 0.00% | – |
| Q1 2019 | $153,000 | +12.5% | 10,412 | -27.0% | 0.00% | – |
| Q1 2018 | $136,000 | +338.7% | 14,262 | +38.8% | 0.00% | – |
| Q2 2016 | $31,000 | – | 10,274 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |